Gbenga G. Sofowora

1.2k total citations
28 papers, 944 citations indexed

About

Gbenga G. Sofowora is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Gbenga G. Sofowora has authored 28 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Gbenga G. Sofowora's work include Receptor Mechanisms and Signaling (11 papers), Heart Rate Variability and Autonomic Control (10 papers) and Anesthesia and Sedative Agents (6 papers). Gbenga G. Sofowora is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Heart Rate Variability and Autonomic Control (10 papers) and Anesthesia and Sedative Agents (6 papers). Gbenga G. Sofowora collaborates with scholars based in United States, Israel and Finland. Gbenga G. Sofowora's co-authors include Alastair J.J. Wood, Victor Dishy, Hong‐Guang Xie, Richard B. Kim, C. Michael Stein, Mordechai Muszkat, Daniel W. Byrne, Daniel Kurnik, Christoph Stein and Eitan Friedman and has published in prestigious journals such as New England Journal of Medicine, Hypertension and Anesthesiology.

In The Last Decade

Gbenga G. Sofowora

28 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gbenga G. Sofowora United States 19 368 358 215 174 112 28 944
J. F. Giudicelli France 20 547 1.5× 404 1.1× 268 1.2× 166 1.0× 48 0.4× 55 1.2k
Heike Bruck Germany 21 951 2.6× 513 1.4× 379 1.8× 233 1.3× 16 0.1× 42 1.8k
F Lhoste France 19 254 0.7× 184 0.5× 184 0.9× 68 0.4× 38 0.3× 56 906
Gary E. Sander United States 22 583 1.6× 405 1.1× 325 1.5× 208 1.2× 36 0.3× 104 1.4k
Ming Lo France 18 819 2.2× 280 0.8× 278 1.3× 382 2.2× 20 0.2× 59 1.3k
B. F. Robinson United Kingdom 15 638 1.7× 168 0.5× 197 0.9× 115 0.7× 42 0.4× 40 1.1k
L. Craft United States 7 409 1.1× 353 1.0× 164 0.8× 102 0.6× 8 0.1× 9 753
Joseph V. Levy United States 16 221 0.6× 220 0.6× 216 1.0× 67 0.4× 167 1.5× 64 881
G. F. DiBona United States 20 464 1.3× 319 0.9× 206 1.0× 194 1.1× 42 0.4× 38 1.3k
M. Gellai United States 21 498 1.4× 386 1.1× 561 2.6× 113 0.6× 69 0.6× 40 1.4k

Countries citing papers authored by Gbenga G. Sofowora

Since Specialization
Citations

This map shows the geographic impact of Gbenga G. Sofowora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gbenga G. Sofowora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gbenga G. Sofowora more than expected).

Fields of papers citing papers by Gbenga G. Sofowora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gbenga G. Sofowora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gbenga G. Sofowora. The network helps show where Gbenga G. Sofowora may publish in the future.

Co-authorship network of co-authors of Gbenga G. Sofowora

This figure shows the co-authorship network connecting the top 25 collaborators of Gbenga G. Sofowora. A scholar is included among the top collaborators of Gbenga G. Sofowora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gbenga G. Sofowora. Gbenga G. Sofowora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kohli, Utkarsh, André Diedrich, Prince J. Kannankeril, et al.. (2015). Genetic variation in alpha2-adrenoreceptors and heart rate recovery after exercise. Physiological Genomics. 47(9). 400–406. 6 indexed citations
2.
Ghimire, Laxmi V., Mordechai Muszkat, Gbenga G. Sofowora, et al.. (2013). Variation in the α2A adrenoceptor gene and the effect of dexmedetomidine on plasma insulin and glucose. Pharmacogenetics and Genomics. 23(9). 479–486. 12 indexed citations
3.
Posti, Jussi P., Perttu Salo, Saku Ruohonen, et al.. (2013). A polymorphism in the protein kinase C gene PRKCB is associated with α2-adrenoceptor-mediated vasoconstriction. Pharmacogenetics and Genomics. 23(3). 127–134. 4 indexed citations
4.
Kohli, Utkarsh, Pratik P. Pandharipande, Mordechai Muszkat, et al.. (2012). CYP2A6 genetic variation and dexmedetomidine disposition. European Journal of Clinical Pharmacology. 68(6). 937–942. 36 indexed citations
5.
Ghimire, Laxmi V., Utkarsh Kohli, Chun Li, et al.. (2012). Catecholamine pathway gene variation is associated with norepinephrine and epinephrine concentrations at rest and after exercise. Pharmacogenetics and Genomics. 22(4). 254–260. 14 indexed citations
6.
Kohli, Utkarsh, Maureen K. Hahn, Brett A. English, et al.. (2011). Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humans. Pharmacogenetics and Genomics. 21(4). 171–178. 18 indexed citations
7.
Kurnik, Daniel, Mordechai Muszkat, Chun Li, et al.. (2011). Genetic Variations in the α 2A -Adrenoreceptor Are Associated With Blood Pressure Response to the Agonist Dexmedetomidine. Circulation Cardiovascular Genetics. 4(2). 179–187. 18 indexed citations
8.
Muszkat, Mordechai, Daniel Kurnik, Gbenga G. Sofowora, Alastair J.J. Wood, & Christoph Stein. (2010). Independent regulation of α1 and α2 adrenergic receptor-mediated vasoconstriction in vivo. Journal of Hypertension. 29(2). 251–256. 13 indexed citations
9.
Muszkat, Mordechai, Daniel Kurnik, Gbenga G. Sofowora, et al.. (2010). Desensitization of vascular response in vivo: contribution of genetic variation in the α2B-adrenergic receptor subtype. Journal of Hypertension. 28(2). 278–284. 20 indexed citations
10.
Kohli, Utkarsh, Mordechai Muszkat, Gbenga G. Sofowora, et al.. (2009). Effects of variation in the human α2A‐ and α2C‐adrenoceptor genes on cognitive tasks and pain perception. European Journal of Pain. 14(2). 154–159. 26 indexed citations
11.
Kurnik, Daniel, Eitan Friedman, Mordechai Muszkat, et al.. (2008). Genetic variants in the α2C-adrenoceptor and G-protein contribute to ethnic differences in cardiovascular stress responses. Pharmacogenetics and Genomics. 18(9). 743–750. 20 indexed citations
12.
Kurnik, Daniel, Chun Li, Gbenga G. Sofowora, et al.. (2008). Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade. Pharmacogenetics and Genomics. 18(10). 895–902. 47 indexed citations
13.
Muszkat, Mordechai, Gbenga G. Sofowora, Hong‐Guang Xie, Alastair J.J. Wood, & Christoph Stein. (2005). ??2B Adrenergic receptor 301???303 deletion polymorphism and vascular ??2 adrenergic receptor response. Pharmacogenetics and Genomics. 15(1). 23–28. 14 indexed citations
14.
Muszkat, Mordechai, Daniel Kurnik, Joseph F. Solus, et al.. (2005). Variation in the ??2B-adrenergic receptor gene (ADRA2B) and its relationship to vascular response in vivo. Pharmacogenetics and Genomics. 15(6). 407–414. 28 indexed citations
15.
Dishy, Victor, Ruth Landau, Gbenga G. Sofowora, et al.. (2004). β2-adrenoceptor Thr164Ile polymorphism is associated with markedly decreased vasodilator and increased vasoconstrictor sensitivity in vivo. Pharmacogenetics. 14(8). 517–522. 41 indexed citations
16.
Ajayi, A.A., et al.. (2003). Adjunctive sympathoplegic therapy to ACE inhibition in Blacks with congestive heart failure: a comparison of alpha-1 with beta-1 blockade on exercise tolerance and cardiac sympathovagal reflex activity.. PubMed. 13(1). 71–9. 5 indexed citations
17.
Dishy, Victor, Gbenga G. Sofowora, Hitoshi Imamura, et al.. (2003). Nitric oxide production decreases after salt loading but is not related to blood pressure changes or nitric oxide-mediated vascular responses. Journal of Hypertension. 21(1). 153–157. 38 indexed citations
18.
Sofowora, Gbenga G., Victor Dishy, Hong‐Guang Xie, et al.. (2001). In-vivo effects of Glu298Asp endothelial nitric oxide synthase polymorphism. Pharmacogenetics. 11(9). 809–814. 44 indexed citations
19.
Xie, Hong‐Guang, Victor Dishy, Gbenga G. Sofowora, et al.. (2001). Arg389Gly ??1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo. Pharmacogenetics. 11(3). 191–197. 89 indexed citations
20.
Dishy, Victor, Gbenga G. Sofowora, Hong‐Guang Xie, et al.. (2001). The Effect of Common Polymorphisms of the β2-Adrenergic Receptor on Agonist-Mediated Vascular Desensitization. New England Journal of Medicine. 345(14). 1030–1035. 294 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. F. Giudicelli Breakdown of academic impact, for papers by Heike Bruck Breakdown of academic impact, for papers by F Lhoste Breakdown of academic impact, for papers by Gary E. Sander Breakdown of academic impact, for papers by Ming Lo Breakdown of academic impact, for papers by B. F. Robinson Breakdown of academic impact, for papers by L. Craft Breakdown of academic impact, for papers by Joseph V. Levy Breakdown of academic impact, for papers by G. F. DiBona Breakdown of academic impact, for papers by M. Gellai
Rankless by CCL
2026